PI4Kbeta/PKG-IN-2 (Compound 20) is an orally active dual inhibitor that targets phosphatidylinositol 4-kinase beta (PI4Kbeta) and cGMP-dependent protein kinase (PKG) in Plasmodium. It demonstrates significant inhibitory effects on Plasmodium and holds potential for use in malaria research.
Target-Kategorie:
PI4K|||PKA|||Parasite
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
